Trial Profile
Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Exemestane (Primary) ; Lipids; Tamoxifen
- Indications Advanced breast cancer; Breast cancer; Menopause
- Focus Pharmacodynamics; Therapeutic Use
- 16 Sep 2008 Results published in JCO.
- 03 Sep 2005 New trial record.